Fox, S., Generali, D., Berruti, A., Brizzi, M., Campo, L., Bonardi, S., . . . Harris, A. (2011). The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
Chicago Style (17th ed.) CitationFox, S., et al. The Prolyl Hydroxylase Enzymes Are Positively Associated with Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor in Human Breast Cancer and Alter in Response to Primary Systemic Treatment with Epirubicin and Tamoxifen. 2011.
MLA (9th ed.) CitationFox, S., et al. The Prolyl Hydroxylase Enzymes Are Positively Associated with Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor in Human Breast Cancer and Alter in Response to Primary Systemic Treatment with Epirubicin and Tamoxifen. 2011.